Iberiabank Corp acquired a new position in shares of Clorox Co (NYSE:CLX) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 2,878 shares of the company’s stock, valued at approximately $433,000.
Other hedge funds also recently made changes to their positions in the company. Cornerstone Wealth Management LLC acquired a new stake in shares of Clorox during the 2nd quarter worth approximately $105,000. Ostrum Asset Management acquired a new stake in shares of Clorox during the 1st quarter worth approximately $112,000. Fort L.P. bought a new position in shares of Clorox in the 2nd quarter worth $129,000. Whittier Trust Co. of Nevada Inc. lifted its holdings in shares of Clorox by 1,297.4% in the 2nd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,621 shares of the company’s stock worth $148,000 after purchasing an additional 1,505 shares in the last quarter. Finally, IMS Capital Management bought a new position in shares of Clorox in the 2nd quarter worth $161,000. 78.36% of the stock is owned by institutional investors.
Shares of CLX opened at $144.84 on Friday. Clorox Co has a 12-month low of $113.57 and a 12-month high of $153.38. The company has a current ratio of 1.09, a quick ratio of 0.67 and a debt-to-equity ratio of 3.15. The firm has a market capitalization of $19.21 billion, a P/E ratio of 23.14, a PEG ratio of 3.11 and a beta of 0.36.
Clorox (NYSE:CLX) last issued its quarterly earnings data on Thursday, August 2nd. The company reported $1.66 earnings per share for the quarter, beating the consensus estimate of $1.58 by $0.08. Clorox had a return on equity of 103.18% and a net margin of 13.44%. The business had revenue of $1.69 billion for the quarter, compared to analysts’ expectations of $1.72 billion. During the same period last year, the business earned $1.53 EPS. The business’s revenue was up 2.7% on a year-over-year basis. As a group, sell-side analysts forecast that Clorox Co will post 6.41 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 16th. Shareholders of record on Wednesday, October 31st will be paid a dividend of $0.96 per share. This represents a $3.84 annualized dividend and a yield of 2.65%. The ex-dividend date is Tuesday, October 30th. Clorox’s dividend payout ratio (DPR) is presently 61.34%.
In other Clorox news, COO Dawn C. Willoughby sold 3,387 shares of the firm’s stock in a transaction on Wednesday, September 5th. The stock was sold at an average price of $148.01, for a total transaction of $501,309.87. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, EVP Jon M. Balousek sold 3,354 shares of the firm’s stock in a transaction on Wednesday, August 29th. The shares were sold at an average price of $144.73, for a total value of $485,424.42. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 29,268 shares of company stock worth $4,196,686. Company insiders own 1.00% of the company’s stock.
A number of equities analysts recently issued reports on the company. UBS Group assumed coverage on Clorox in a report on Wednesday, July 18th. They issued a “sell” rating and a $110.00 target price on the stock. BMO Capital Markets reiterated a “buy” rating and issued a $153.00 target price on shares of Clorox in a report on Friday, August 3rd. Deutsche Bank cut Clorox from a “hold” rating to a “sell” rating and set a $123.00 target price on the stock. in a report on Wednesday. ValuEngine upgraded Clorox from a “hold” rating to a “buy” rating in a report on Saturday, September 22nd. Finally, Zacks Investment Research upgraded Clorox from a “hold” rating to a “buy” rating and set a $171.00 target price on the stock in a report on Wednesday, October 3rd. Four research analysts have rated the stock with a sell rating, eight have given a hold rating and four have issued a buy rating to the stock. Clorox currently has an average rating of “Hold” and an average target price of $137.21.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Recommended Story: Calculate Your Return on Investment (ROI)
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.